Advertisement
Screener

Palvella Therapeutics, Inc. (PVLA) Material Contracts, 2015

Palvella Therapeutics, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2015-11-13: Form 10-Q; Exhibit 10.3; Description Sublease Agreement by and between the Company and Berenberg Capital Markets, LLC, dated as of August 27, 2015..
  • 2015-11-13: Form 10-Q; Exhibit 10.2; Description Employment Agreement by and between Darlene Deptula-Hicks and the Company, effective as of August 27, 2015..
  • 2015-11-13: Form 10-Q; Exhibit 10.1; Description Employment Agreement by and between Louis Matis, M.D. and the Company, effective as of July 20, 2015..
  • 2015-03-30: Form 10-K; Exhibit 10.10; Description RESEARCH AND LICENSING AGREEMENT.
FiledFormExhibitDescription
2015-11-1310-Q10.3Sublease Agreement by and between the Company and Berenberg Capital Markets, LLC, dated as of August 27, 2015.
2015-11-1310-Q10.2Employment Agreement by and between Darlene Deptula-Hicks and the Company, effective as of August 27, 2015.
2015-11-1310-Q10.1Employment Agreement by and between Louis Matis, M.D. and the Company, effective as of July 20, 2015.
2015-03-3010-K10.10RESEARCH AND LICENSING AGREEMENT
2015-03-3010-K10.9JOINT DEVELOPMENT & LICENSE AGREEMENT
2015-03-3010-K10.8DEVELOPMENT AND LICENSE AGREEMENT
2015-03-3010-K10.7Collaboration Research and Technology Licensing Agreement
2015-03-3010-K10.4COLLABORATION AND LICENSE AGREEMENT

Similar stocks

Stock NameCountryMarket CapPE Ratio
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Generate Biomedicines, Inc. (GENB)United States$2.052B
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12